近日,广药集团旗下子公司白云山中一药业迎来国际化战略发展的重要突破:拳头产品安宫牛黄丸正式获得由越南卫生部传统药物管理局颁发的药品注册证书,以药品身份成功进入越南市场。这一突破性进展,标志着白云山中一药业在东南亚市场的深耕布局取得关键硕果,为中越医药健康合作注入了新的动能,进一步夯实了中医药国际化的发展路径。白云山中一安宫牛黄丸在越南注册成功百年匠心铸精品药品实力获国际认可作为岭南中医药文化的璀璨...
Source Link近日,广药集团旗下子公司白云山中一药业迎来国际化战略发展的重要突破:拳头产品安宫牛黄丸正式获得由越南卫生部传统药物管理局颁发的药品注册证书,以药品身份成功进入越南市场。这一突破性进展,标志着白云山中一药业在东南亚市场的深耕布局取得关键硕果,为中越医药健康合作注入了新的动能,进一步夯实了中医药国际化的发展路径。白云山中一安宫牛黄丸在越南注册成功百年匠心铸精品药品实力获国际认可作为岭南中医药文化的璀璨...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.